Episode 20: Professor Bertil E. Lindmark MD, PhD, Author and CMO at Galecto, Inc.

Episode 20 May 18, 2022 00:30:43
Episode 20: Professor Bertil E. Lindmark MD, PhD, Author and CMO at Galecto, Inc.
Few & Far Between: Conversations from the Front Lines of Drug Development
Episode 20: Professor Bertil E. Lindmark MD, PhD, Author and CMO at Galecto, Inc.

May 18 2022 | 00:30:43

/

Show Notes

What do the next 100 years have in store for healthcare and clinical research? Biorasi's Few & Far Between podcast welcomes Professor Bertil E. Lindmark MD, PhD, author and CMO at Galecto, Inc., for an in-depth discussion on the biological revolution and trends in the life sciences.

Other Episodes

Episode 37

January 24, 2024 00:41:31
Episode Cover

Episode 37: Will Greene, Prader-Willi Syndrome patient advocate, Healthcare Engagement Lead at Roche

"The history of rare disease drug development indicates that once you start looking harder for cases, you often tend to find them." - Will...

Listen

Episode 19

April 20, 2022 00:36:19
Episode Cover

Episode 19: Leslie Michelson, Founder and CEO, Private Health Management

How do you obtain the best possible patient care available? On this week's Few & Far Between podcast, host Chris O'Brien welcomes patient advocacy...

Listen

Episode 5

July 07, 2021 00:51:14
Episode Cover

Episode 5: Will Maier, VP of Rare Disease, Drug Development Sciences at ICON plc

On today’s podcast, host Wayne Bowden, Vice President of Partnerships and Strategy at Biorasi, talks with Will Maier, VP of Rare Disease, Drug Development...

Listen